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Background. Patient movement has been considered an important source of errors in
cardiac PET. This study was aimed at evaluating the effects of such movement on myocardial
blood ﬂow (MBF) and perfusable tissue fraction (PTF) measurements in intravenous
15O-water
PET.
Methods. Nineteen
15O-water scans were performed on ten healthy volunteers and three
patients with severe cardiac dysfunction under resting conditions. Motions of subjects during
scans were estimated by monitoring locations of markers on their chests using an optical
motion-tracking device. Each sinogram of the dynamic emission frames was corrected for
subject motion. Variation of regional MBF and PTF with and without the motion corrections
was evaluated.
Results. In nine scans, motions during
15O-water scan (inter-frame (IF) motion) and
misalignments relative to the transmission scan (inter-scan (IS) motion) larger than the spatial
resolution of the PET scanner (4.0 mm) were both detected by the optical motion-tracking
device. After correction for IF motions, MBF values changed from 0.845 ± 0.366 to
0.780 ± 0.360 mL/minute/g (P < .05). In four scans with only IS motion detected, PTF values
changed signiﬁcantly from 0.465 ± 0.118 to 0.504 ± 0.087 g/mL (P< .05), but no signiﬁcant
change was found in MBF values.
Conclusions. This study demonstrates that IF motion during
15O-water scan at rest can be
source of error in MBF measurement. Furthermore, estimated MBF is less sensitive than PTF
values to misalignment between transmission and
15O-water emission scans. (J Nucl Cardiol
2012;19:524–33.)
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INTRODUCTION
Positron emission tomography (PET) has been
extensively utilized for a wide range of non-invasive
functional imaging of the myocardium in vivo. When
using this method, the global body movements of
patients could be a source of quantitative errors. Such
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524movement could be particularly problematic when scans
are carried out for a relatively long period.
1,2 Problems
also arise when studies are carried out during physio-
logically stressed conditions, e.g., a cycling exercise in
the PET scanner.
3 Errors can be attributed not only to
the mismatch between the emission and the transmission
data but also to the patient motion during each of the
emission and/or the transmission scans.
3
15O-water PET studies provide quantitative infor-
mation regarding myocardial blood ﬂow (MBF) and
coronary ﬂow reserve (CFR), as well as a marker of
myocardial viability, termed the water perfusable tissue
fraction (PTF) or water perfusable tissue index (PTI).
4-12
The distribution of radioactivity during
15O-water PET
varies over time; this poses challenges for software-
based correction of patient movement. Naum et al
proposed to correct for such motion based on the rigid
body model by aligning two external radioactive mark-
ers on the back of each subject. This study was
conducted by performing dynamic scans while the
subjects were under resting conditions and engaged in
a cycling exercise.
3 Although no correction was made
for the misalignment between transmission and emission
scans, their study demonstrated reasonable improvement
in calculated MBF values.
In our previous work, we developed an alternative
system that uses an optical motion-tracking device to
detect and correct for the patient’s global movement
during a cardiac
15O-water PET study.
13 Our system
provides a correction for movement during dynamic
scanning, as well as for misalignment between the
transmission and the emission scans, to compensate for
errors in attenuation correction procedures. We evalu-
ated and methodologically validated the inherent
accuracy of this system in a cardiac phantom study.
The correction for simulated global movement in a
15O-
water cardiac PET study of a healthy volunteer has also
demonstrated reasonable regional MBF values, com-
pared to values not adjusted for movement.
The purpose of this study was to evaluate the effects
of global movements of subjects on quantiﬁcation of
MBF and PTF. Our previously validated system was
used to detect and correct for the global movements of
healthy volunteers, as well as patients who have suffered
from severe cardiac dysfunction, during
15O-water PET
studies under resting conditions.
METHODS
Subjects
Subjects consisted of 10 healthy volunteers and 3 patients
with previous myocardial infarction. The volunteers were all
male, 22-32 years of age (mean ± 1standard deviation (SD)
25 ± 3 years). The volunteers had no signs or symptoms of
ischemic heart disease. Patients were studied before and after
the cell transplantation therapy with autologous myoblast
sheets (AMS).
14,15 Scans were carried out by independent
clinical research project, but were included in this study by
mutual agreement. Two of the patients were male, the other
was female; patients were 43-63 years of age. All patients had
left ventricular assist systems (LVASs) at the time of PET
study, except for one patient who received LVAS after the ﬁrst
PET and before the second PET studies. The PET studies were
carried out 67-104 days (mean ± SD 82 ± 19 days) after the
implantation of LVASs, and 26-106 days (mean ± SD
56 ± 44 days) after AMS transplantation therapy. All subjects
gave written informed consent according to a protocol
approved by the Ethical Committee and Internal Review
Board of Osaka University.
PET Scan
The PET scanner was a HEADTOME-V tomograph
(SHIMADZU Corp., Kyoto, Japan).
16 All data were acquired
in 2D mode. Reconstructed images were obtained using a
ﬁltered back-projection algorithm with a Gaussian ﬁlter of
9 mm (full width at half maximum). The matrix and voxel
sizes of reconstructed image were 128 9 128 9 63 and
2.03 9 2.03 9 3.13 mm
3, respectively. No scatter correction
was applied to the image reconstruction.
Each subject was laid on the bed of the PET camera
without any ﬁxation of the body, and scanned at rest. A
transmission scan was carried out ﬁrst for correction of photon
attenuation (20 minutes on the healthy volunteers, 10-15 min-
utes on the patients). A
15O-CO emission scan for blood pool
imaging was initiated 8 minutes after inhalation of
15O-CO gas
for 2 minutes (3.0-3.2 GBq). The
15O-water dynamic emission
scan was then carried out following intravenous administration
of
15O-water (1.1 GBq over 40 seconds) into the brachial vein,
except for one patient who received the administration via
right femoral vein.
15O-water scans were performed for
6 minutes, using 26 dynamic frames consisting of 12 9 5s ,
8 9 15 s, and 6 9 30 s.
15O-water scans were performed only
once on eight healthy volunteers; two of the volunteers
underwent
15O-water scans twice. Thus, a total of twelve
15O-
water scans were carried out on the healthy volunteers. One
patient underwent PET scans three times (before and after the
implantation of LVAS, and after the cell transplantation
therapy); the other two were scanned twice (before and after
the cell transplantation therapy). Thus, a total of seven PET
studies were carried out on the patients.
Motion Detection and Correction
Subject motion during cardiac
15O-water PET was
detected using an optical motion-tracking device, POLARIS
(Northern Digital Inc., Canada). This method for motion
correction (MC) is based on a rigid body model, and performed
on each sinogram of the dynamic frame to correct for inter-
scan (IS) and inter-frame (IF) motions, as shown in Figure 1.
The correction process was performed automatically, based on
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POLARIS, sinograms, and reconstruction parameters. In this
manuscript, the IS motion denotes global motion between
transmission and the ﬁrst frame of
15O-water emission scan;
the IF motion, which is in addition to the IS motion, denotes
global motion between frames of the
15O-water scan. Meth-
odological details regarding detection and correction of the
motions are described in our previous studies.
13,17,18
Motion Classiﬁcation
Global movement during
15O-water scan was character-
ized as consisting of IS and IF motions. Accordingly, motion
was classiﬁed as: (1) IS ? IF, in which both IS and IF
motions were present; (2) IS motion only; (3) IF motion only;
and (4) neither type of movement was present (NE). The
presence of each IS and IF motion was determined as
described below. Using values txðiÞ; tyðiÞ; and tzðiÞ to
represent translational movement in the x, y, and z, respec-
tively, directions between the transmission and the ith frame
of the
15O-water scans, IS motion was considered signiﬁcant
if
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
txð1Þ
2 þ tyð1Þ
2 þ tzð1Þ
2
q
[4:0mm; where the value of
4.0 mm was the intrinsic spatial resolution of the PET
scanner.
16
IF motion was considered to be signiﬁcant if
max
i
LðiÞ;HðiÞ fg [4:0mm; where L(i) represents the gradual
movement of the subject during the scan, and H(i) denotes the
motion between adjacent frames. These two components of the
IF motion can be expressed as
LðiÞ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ X
w¼x;y;z
twðiÞ twð1Þ ½ 
2
s
ð1aÞ
HðiÞ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ X
w¼x;y;z
twðiÞ twði   1Þ ½ 
2
s
ð1bÞ
Motion Effect Evaluation
To evaluate motion effects on perfusion and viability
measurements, we estimated regional MBF and PTF values for
nine myocardial segments (anterior, lateral, posterior, and
septal wall regions at middle and basal levels, as well as apex)
with and without MCs, as described in the following section.
Percent differences in the estimated values between with and
without MCs for the nine myocardial regions were statistically
tested using a one-way ANOVA to ﬁnd myocardial segments
sensitive to global movement. The percent differences were
employed owing to avoiding difference of physiological states
cross the subjects. The percent difference was deﬁned by
%DqðiÞ¼100   qWðiÞ qWOðiÞ jj =qWOðiÞ; where qW(i) and
qWO(i) are MBF or PTF values, respectively, for the ith
myocardial segment with and without MCs. Absolute values of
MBF and PTF with and without MCs for each group were also
assessed using Bland-Altman analysis and a paired 2-tailed t
test. In the IS ? IF motion group, to assess the effects of IS
and IF motions, additional MBF and PTF estimations were
performed on the data from
15O-water images corrected for IS
motions (IS ? IF - IS) and also on data corrected for IF
motions (IS ? IF - IF). The quantitative values obtained
from IS ? IF - IS data were considered to be affected by IF
Figure 1. Schematic diagram of the correction for IS and IF motions.
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were considered to be affected by IS motion. The estimated
values were compared to those without MCs using a paired
2-tailed t test. P values \.05 were considered statistically
signiﬁcant. Data was expressed as mean ± 1SD.
MBF and PTF Estimation
Regional MBF and PTF were obtained using the single
tissue compartment model with correction for partial volume
effects and spillover from the left ventricular cavity (LV)
CðtÞ¼MBF   PTF   CaðtÞ exp  
MBF
p
t
  
þ Va   CaðtÞ
where C(t) represents the segment tissue time-activity curve
(TTAC), Ca(t) represents the arterial time-activity curve, p is
the partition coefﬁcient of water in the myocardial tissue
(0.91 mL/g), and Va is the arterial blood volume and spillover
fraction from LV.
19 TTACs were generated for the nine
myocardial segments using regions of interest (ROIs) selected
within each
15O-water myocardial image with and without
MCs. The myocardial image was obtained by subtraction of
the early phase of the dynamic
15O-water image from the later
phase. The midpoint between two phases was determined for
each
15O-water image using the contrast between myocardial
regions and LV cavities. To obtain Ca(t), a ROI was ﬁrst drawn
on a motion-corrected
15O-CO image, without regard to
whether MC had been applied to the
15O-water image. The
recovery coefﬁcient of the LV was calculated from the ROI
count on the
15O-CO image and the blood radioactivity
concentration. Second, the ROI was transformed to the
15O-
water image coordinate using a motion matrix that represents
misalignment between transmission and the ﬁrst dynamic
frame of the
15O-water scans. This transformation was made to
evaluate motion effects on the
15O-water scan, excluding
effects of misalignment between
15O-CO and
15O-water scans.
Using the transformed ROI, the LV TAC of the
15O-water
image was calculated. Finally, Ca(t) was derived using the LV
TAC and the overall TTAC was generated from nine myocar-
dial segments according to the previous method.
6 To
demonstrate the inﬂuence of IS motion, the ROI-based
approach was not used; instead, pixel-by-pixel MBF and
PTF values were estimated for a representative normal scan.
20
To denoise and smooth these parametric images, MBF and
PTF were set to zero in voxels with PTF\0.3 g/mL or
Va[0.8 mL/mL, and then ﬁltered using a Gaussian ﬁlter of
14 mm (full width at half maximum).
21 For normal scans in
the group, improvement of homogeneity between myocardial
segments by MC was also evaluated as 100  ð 1  
SDW=SDWOÞ; where SDW and SDWO were standard deviations
of regional values with and without MCs, respectively.
RESULTS
Table 1 shows global movement during
15O-water
scans, categorized by the presence of IS and IF motions.
Thirteen scans (7 scans on healthy volunteers and 6
scans on patients) exhibited IS motions greater than
4.0 mm, and 10 scans (5 scans on healthy volunteers and
5 scans on patients) exhibited IF motions greater than
4.0 mm. Among these, 4 scans on healthy volunteers
and 5 scans on patients showed both IS and IF motions.
There was no statistically signiﬁcant difference
between the ROI volumes of
15O-water images with and
without MCs for IS, IF, and NE motion groups by paired
2-tailed t tests, and between the volumes with and
without MCs, IS ? IF - IS, and IS ? IF - IF motion
for IS ? IF motion group by a one-way ANOVA.
Table 2 lists MBF and PTF values with and without
MCs categorized by the four types of movement that
occurred during
15O-water studies, and average percent
differences of MBF and PTF values over nine segments.
Among 171 myocardial segments from all subjects, the
ﬁtting program failed to provide physiologically mean-
ingful values in two segments (middle and basal septa
for a healthy volunteer, in which IS ? IF motion was
detected) in the absence of MC. Those data were
excluded from subsequent analysis. Among MBF val-
ues, signiﬁcant changes by MCs were found in the
IS ? IF, IS ? IF - IF, and IF motion groups: for
IS ? IF, from 0.845 ± 0.366 to 0.769 ± 0.319 mL/min-
ute/g (P\.05); for IS ? IF - IF, from 0.845 ± 0.366
to 0.780 ± 0.360 mL/minute/g (P\.05); and for IF,
from 0.854 ± 0.179 to 1.088 ± 0.154 mL/minute/g
(P\.01). PTF values in the IS motion group changed
signiﬁcantly from 0.465 ± 0.118 to 0.504 ± 0.087 g/mL
(P\.05). This signiﬁcant change is also shown in
Figures 2 and 3, as differences between PTF values with
and without MCs. In Figure 3, a data point indicated an
averaged value for each scan.
Figure 4 illustrates the effect of IS motion of
5.0 mm on MBF and PTF of a normal subject from
the IS motion group. The polar maps of normal PTF
in Figure 4 demonstrate improvement of homogene-
ity in anterolateral regions by MC. Improvements of
homogeneity of three normal scans in the group
were 2.6% ± 26.1% for MBF and 30.9% ± 22.7% for
PTF.
Table 1. Characteristics of motion during
15O-
water scans
Motion
type
Total
(normal)
scans
IS
motion
(mm)
IF
motion
(mm)
IS ? IF 9 (4) 7.7 ± 2.7 11.0 ± 4.0
IS 4 (3) 5.4 ± 1.0 2.8 ± 1.1
IF 1 (1) 2.7 5.1
NE 5 (4) 2.5 ± 0.7 1.4 ± 0.5
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15O-water cardiac PETRelative variability of regional MBF and PTF values
due to global motion are shown in Figures 5 and 6,
respectively. For MBF and PTF values in each motion
group including the IS ? IF - IS and IS ? IF - IF
groups, no signiﬁcant difference between myocardial
segments was observed in a one-way ANOVA (IF
Table 2. The summary of MBF and PTF values with and without MCs
Motion type Without MC With MC Percent difference
MBF (mL/minute/g)
IS ? IF 0.845 ± 0.366 0.769 ± 0.319* 33.8 ± 61.5
IS ? IF - IS 0.815 ± 0.341 21.2 ± 38.5
IS ? IF - IF 0.780 ± 0.360* 25.1 ± 41.4
IS 0.855 ± 0.343 0.828 ± 0.259 9.0 ± 8.9
IF 0.854 ± 0.179 1.088 ± 0.154
  30.2 ± 20.9
NE 0.898 ± 0.233 0.909 ± 0.221 9.7 ± 15.7
PTF (g/mL)
IS ? IF 0.476 ± 0.133 0.469 ± 0.128 13.9 ± 10.9
IS ? IF - IS 0.471 ± 0.135 12.3 ± 13.0
IS ? IF - IF 0.490 ± 0.119 12.3 ± 10.2
IS 0.465 ± 0.118 0.504 ± 0.087* 9.0 ± 9.6
IF 0.512 ± 0.067 0.483 ± 0.068 7.1 ± 5.6
NE 0.488 ± 0.095 0.496 ± 0.100 5.1 ± 4.9
IS, Inter-scan; IF, inter-frame.
NE denotes motion B4.0 mm. IS ? IF - IS and IS ? IF - IF represent IS ? IF motion groups with correction of IS and IF motions,
respectively.
* P\.05,
  P\.01 vs without MC.
Figure 2. Differences between PTF values with and without the motion corrections. IS, Inter-scan
motion; IF, inter-frame motion; NE, no signiﬁcant motion. IS ? IF - IS and IS ? IF - IF are
groups corrected for IS and IF motion in the IS ? IF group, respectively.
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one scan was assigned to this group. Data for IS ? IF -
IS and IS ? IF - IF group were not shown).
DISCUSSION
In this study, global movements of the subjects
during
15O-water PET scans at rest were categorized as
IS and IF motions. IS motion involves misalignment
relative to the transmission scan, whereas IF motions
involves changes between the dynamic frames during
the
15O-water scan. After categorization, the effects of
these motions on MBF and PTF measurements were
evaluated. Consequently, it was demonstrated that
MBF values are affected by IF motion rather than IS
motion.
Investigation of regional sensitivity to global move-
ment resulted in no signiﬁcant difference in regional
MBF or PTF. This is because the direction and the
magnitude of global movement varied for each subject;
under- and over-estimation of MBF and PTF due to the
motion could have occurred in any myocardial region. In
this study, we utilized a one-way ANOVA to detect
segmental differences. Due to small sample sizes, the
ANOVA may fail to detect the differences. Correlation
between segmental differences and the directions of
global motions, especially IS motion, effects of which
have been reported for misregistration between CT
Figure 3. Changes in PTF values in the absolute scale by the MCs. IS, Inter-scan motion; IF, inter-
frame motion; NE, no signiﬁcant motion. IS ? IF - IS and IS ? IF - IF are groups corrected for
IS and IF motion in the IS ? IF group, respectively. A data point indicates an averaged value for
each scan.
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22,23 could be
observed in large population study.
MBF values changed signiﬁcantly upon correction
for IF motions in the IF, IS ? IF, and IS ? IF - IF
motion groups. In contrast, correction of IS motion was
considered to have little effect, based on the results from
the IS ? IF - IS and IS motion groups in Table 2.I t
was further demonstrated that IF motion, but not IS
motion, was an important source of error in the MBF
measurement. The signiﬁcant but small changes in MBF
of IF, IS ? IF, and IS ? IF - IF motion groups after
MCs could be due to the relatively large number of
healthy volunteer scans in each group (1 of 1 scan for IF,
4 of 9 scans for IS ? IF, respectively), as shown in
Table 1. Suppression of IF motion during the
15O-water
scan is needed for accurate MBF measurement. For the
IS motion groups, no signiﬁcant change in MBF values
and signiﬁcant change in PTF values were observed by
MCs (Figures 2, 3). For the normal scans in the group,
the improvement of regional homogeneity was also
observed in PTF rather than MBF. This is because the
MBF values obtained using the kinetic model employed
in this study were based on a clearance rate assessment
of
15O-water rather than the uptake rate of the radio-
tracer.
5 This is consistent with the ﬁndings of Lubberink
et al,
21 who reported that MBF values do not change
even if attenuation correction is omitted; this correction
only caused changes in the absolute scale of TTAC,
which then caused changes in PTF values. IS motions
were also detected in the IS ? IF motion group. For the
IS ? IF - IS motion group, in which IS motions were
corrected, no signiﬁcant change in PTF values was
observed after MCs. This might be because IS and IF
motions affected the
15O-water images not subjected to
MC in such a way as to cancel out errors in PTF
measurements. PTF values were considered to be more
affected than MBF values during the wash-in phase.
However, in our study, IF motion had little effect on
PTF values for the IS ? IF - IF and IF groups, as
shown in Table 2. The reasons for this discrepancy are
follows: (1) to estimate the quantitative values, a
nonlinear least squares method with same weights for
all data points were applied to the data corrected for the
physical decay. This ﬁtting manner could be sensitive to
radioactivity concentration in wash-out phase rather than
wash-in phase. (2) Over-estimation in TTAC was
introduced by contamination of the LV cavity count,
using the ROI for TTAC superimposed on dynamic
frames. However, the spillover correction could sup-
press the inﬂuence of IF motion. One of the advantages
of
15O-water over other cardiac PET tracers is that
perfusion and viability measurements can be obtained
from a single PET scan with short duration. Because
accurate PTF measurement enabled assessment of
Figure 4. Effect of an IS motion of 5.0 mm on MBF and PTF of a normal subject in IS motion
group.
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7-12 correction of IS motion, the
effect of which was shown as the improvement of
regional homogeneity of normal PTF in Figure 4,i s
considered to be important in the diagnosis of myocar-
dial infarction, or evaluation of effects of cell
transplantation therapies.
In this study, we performed
15O-CO scans to
determine a recovery coefﬁcient for each subject.
5,6
15O-water PET studies without
15O-CO scans have been
reported in previous papers
3,21,24; in these studies, the
recovery coefﬁcient could be ﬁxed, or assumed to have a
constant value. Omission of the
15O-CO scan shortened
the examination time, and might reduce motion arte-
facts. However, we considered that the adequacy of
using a ﬁxed recovery coefﬁcient is still an unresolved
issue in
15O-water PET. We considered that the changes
in MBF and PTF resulting from MCs were due to
correction for global motion, and not due to variability
of myocardial tissue ROIs drawn manually on
15O-water
images. We employed nine segmented regions rather
than 17-segment AHA standard model for suppressing
relatively large noise level of
15O-water data.
4 In
addition, the volumes of the ROIs for each motion
group before and after MCs were almost equal (not
statistically signiﬁcant). Furthermore, lower sensitivity
of MBF values to variation in ROI size and shape was
demonstrated by Iida et al.
4 In this study, global motion
might have occurred because subjects were scanned
without any ﬁxation. Although tight ﬁxation prevents
patient motion, such ﬁxation could bring discomfort or
pain to the patient; subsequent reaction to such pain
could itself induce motion.
One limitation of this study is that all subjects were
scanned at rest. When pharmacological or physiological
stressors are administered, motion artefacts could be
induced, as shown by Naum et al
3 in the context of
physiological stress conditions. Our ﬁnding that MBF
was sensitive to IF motion rather than IS motion was
considered to be valid for a stress study; IF motion
might be source of severe error in MBF and CFR
measurements. The rigid body model, which was used in
this study, has been promoted for motion compensation
not only in brain PET but also in cardiac PET. McCord
et al
1 employed the rigid body model to correct for
misalignment during the transmission and
18F-ﬂuorode-
oxyglucose (
18F-FDG) emission scans. Bacharach et al
2
Figure 5. Relative variability of regional MBF due to effects of global motion. IS, Inter-scan
motion; IF, inter-frame motion; NE represents no signiﬁcant motion. IS ? IF - IS and IS ? IF -
IF are groups corrected for IS and IF motion in the IS ? IF group, respectively.
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body model for
18F-FDG emission images acquired on
different days. The use of the rigid body model is
considered to be valid for non-gated cardiac PET images
because the images were smoothed spatially due to
cardiac wall motion, and also averaged temporally over
the duration of the dynamic frames. However, in stress
studies, over-correction due to relatively large respira-
tory motions might be introduced by our system because
the subject’s motion was estimated by measurement of
the location of a target attached on the thoracic surface.
With this in mind, further work is necessary to evaluate
the contribution of MC in combination with a respira-
tory gating technique.
The MC system was applied to clinical follow-up
studies of the patients who received LVAS and cell
transplantation therapy. The aim of this study was to
investigate the effects of global movement on quantiﬁ-
cation of MBF and PTF values in a single
15O-water
PET study under resting conditions. Although, we
believed that the MC system could contribute to an
accurate evaluation of regional perfusion and viability,
the effects of LVAS implantation and AMS
transplantation therapy on those patients is beyond the
scope of the present study, and will be studied
elsewhere.
CONCLUSIONS
This study demonstrated that IF motion during
15O-
water scans under resting conditions could be the source
of error in MBF measurement. Furthermore, estimated
MBF values were less sensitive than PTF values to
misalignment between the transmission and the
15O-
water emission scans.
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